The new U.S. FDA Commissioner Scott Gottlieb hit the ground running with an all-staff meeting at the regulatory agency to lay out his priorities and goals.
Four months after Luke Miels was hired away by GlaxoSmithKline, AstraZeneca filed a lawsuit claiming Miels is in violation of his employee contract.
A county in New York state has sued Purdue Pharma LP, Johnson & Johnson and other drugmakers, accusing them of engaging in fraudulent marketing that played down the risks of prescription opioid painkillers, leading to a drug epidemic.
Influencer marketing done right can make a big splash.
Mesmerize Marketing Announces Acquisition of Elite Sampling & Media Group’s Network of Doctors’ Office Wallboards
Mesmerize Marketing, an established leader in patient education at the point of care (POC) since 2006, announced that it acquired Elite Sampling & Media Group’s national network of doctors’ office wallboards.
Ionis Pharmaceuticals said its Phase III study of inotersen to treat patients with familial amyloid polyneuropathy (FAP) met primary and secondary endpoints.
Physicians say most of what they get from drug companies online is just advertising and they feel few pharmas are doing a good job at providing quality digital content.
Fitbit, the leader in connected health and fitness wearables, for this first time identified its list of Fittest Countries as well as the Fittest Cities in the United States.
Sales forecasts for AstraZeneca’s all-important new cancer immunotherapy drug Imfinzi are set to rise after the drugmaker received an unexpectedly early boost for the medicine in lung cancer.
EU antitrust regulators will investigate whether Aspen Pharmacare is charging excessive prices for five key cancer drugs in a move which could lead to a hefty fine for Africa’s largest generic drugmaker.
Thermo Fisher Scientific Inc. snapped up North Carolina-based Patheon N.V. in a deal valued at $7.2 billion.
Biotech innovator Henri Termeer, the longtime chief executive officer of Genzyme and a pioneer in orphan drug development, passed away at the age of 71 years.
The GAVI global vaccine alliance said some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.
Patients with episodic and chronic migraine reported fewer debilitating headaches after using Eli Lilly’s experimental drug compared to those on placebo.
A trial of AstraZeneca’s key immunotherapy drug durvalumab showed it reduced the risk of death from advanced lung cancer.
Shares of Capricor Therapeutics plunged nearly 60 percent in premarket trading after the company announced it was laying off an unknown number of employees following the failure of a mid-stage cardiovascular drug trial.
Neil Woodford, of UK’s Woodford Investment Management, unloaded his company’s shares of London-based GlaxoSmithKline. His concerns include a weak pipeline and few strategic options.
Five major chocolate and candy companies announced a joint commitment to reduce calories in many sweets sold on the U.S. market, a rare example of cooperation in a competitive industry and testament to a rising consumer distaste for sugar.
The world needs greater transparency on the pricing of medicines – and an overhaul of some approaches – in order to increase access to life-saving drugs, global health experts said.
John Mangano was named senior VP, Strategy and Analytics, at Digitas Health – the Agency of Now.